ArticleBritish journal of haematology2025

A phase I/II study of brentuximab vedotin + AVD in paediatric patients with advanced Hodgkin lymphoma.

Marco A Salvino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.